Guava Technologies, Inc. has announced an exclusive partnership with IMV Technologies, world leader in reproductive biotechnology, to provide breeders and scientists with a unique cellular analysis platform that enables better evaluation of fertility parameters by introducing a new level of accuracy, reproducibility, productivity and cost effectiveness for livestock semen analysis.

Performing a panel of simple proprietary tests on a IMV/Guava EasyCyte Mini or IMV/Guava EasyCyte Plus microcapillary flow cytometer delivers a better understanding of sperm cell physiological status enabling Artificial Insemination Centres to better manage semen production and sires.

“Working closely with IMV Technologies we have produced a novel platform that represents a paradigm shift in animal semen quality control,” said Paul Wheeler, VP of Sales and Marketing for Guava Technologies. “Existing techniques are limited in terms of the types of assays they can perform, are slow, not flexible and have low throughput”. He added “The new levels of accuracy, reproducibility, productivity and cost effectiveness are due to the unique attributes of our microcapillary flow cytometers and development of discriminating tests for sperm cell viability, motility, capacitation, acrosomal integrity, DNA fragmentation and bacterial contamination by IMV Technologies”.

Guava Technologies’ patented microcapillary flow cytometers accommodate smaller sample volumes, generate less waste, have lower operating costs, and are easier to set up and maintain than the typical traditional flow cytometer. By leveraging the unique attributes of microcapillary based flow cytometry, the company’s integrated systems enable scientists and clinicians not specialised in the technology to perform complex cellular analyses directly from their own lab bench – quickly, simply, and cost-effectively.

Guava Technologies, Inc. (www.guavatechnologies.com) is a private biotechnology and medical device company that designs and manufactures easy-to-use, on-demand, benchtop cell analysis systems. In 2007, Guava Technologies achieved ISO13485 certification for the design and manufacture of medical devices. All Guava Systems are friendly, delivering turnkey assays that include optimised reagents and assay-specific software for applications such as cell counting/viability, antibody quantification, cell cycle, cytotoxicity, apoptosis, and more. Minimising time from hypothesis to conclusion, Guava Systems are ideal for a broad range of medical and biomedical applications, & are helping scientists around the world understand life one cell at a time.

At the forefront of research, IMV Technologies (www.imv-technologies.com) conceptualises, engineers and markets instruments and technologies covering the entire gamut of operations linked to artificial reproduction, embryo transfer for numerous animal species. Operating through four subsidiaries and a network of distributors in more than 100 countries ensures an in-depth understanding of national markets and their specificities. IMV Technologies is world leader in animal and human reproduction biotechnology, from semen and embryos collection to freezing and is considered a reference regarding reproduction technologies for animals.